Quest Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$1.54M Sell
14,909
-894
-6% -$104K 0.27% 64
2021
Q3
$1.98M Buy
15,803
+99
+0.6% +$12.8K 0.39% 38
2021
Q2
$1.95M Sell
15,704
-770
-5% -$96.7K 0.39% 41
2021
Q1
$1.95M Sell
16,474
-858
-5% -$101K 0.42% 35
2020
Q4
$2.03M Buy
17,332
+862
+5% +$94.9K 0.47% 31
2020
Q3
$1.71M Sell
16,470
-382
-2% -$38.4K 0.47% 32
2020
Q2
$1.54M Sell
16,852
-658
-4% -$63.1K 0.46% 31
2020
Q1
$1.58M Buy
17,510
+586
+3% +$62.3K 0.54% 24
2019
Q4
$1.92M Buy
16,924
+45
+0.3% +$4.94K 0.46% 33
2019
Q3
$1.83M Sell
16,879
-1,766
-9% -$184K 0.45% 32
2019
Q2
$1.82M Buy
18,645
+6,636
+55% +$606K 0.46% 29
2019
Q1
$1.09M Buy
12,009
+7,852
+189% +$703K 0.27% 56
2018
Q4
$378K Buy
+4,157
New +$388K 0.11% 82

Other funds holding MDT

Quest Capital Management's MDT Position: Q4 2021 in Review

Quest Capital Management reduced its Medtronic (MDT) stake by 5.7% in Q4 2021, selling an estimated $104K and leaving 14,909 shares worth $1.54M. The position accounts for 0.27% of the portfolio, ranked #64.

Quest Capital Management first reported a position in MDT in Q4 2018 and has held it in 13 quarters since. The position peaked at $2.03M in Q4 2020. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Quest Capital Management held 14,909 shares of Medtronic worth $1.54M as of Q4 2021.
  • Quest Capital Management sold 894 Medtronic shares in Q4 2021, an estimated $104K.
  • Medtronic made up 0.27% of Quest Capital Management's portfolio in Q4 2021, its #64 holding.
  • Quest Capital Management first reported a position in Medtronic in Q4 2018 and has held it in 13 quarters since.
  • Quest Capital Management's Medtronic position peaked at $2.03M in Q4 2020.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Quest Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.